Quality & complianceOfficial

Class II drug recall: Buprenorphine Hydrochloride (Par Health Usa, Llc)

🇺🇸 FDA enforcement report · Wed 07 Oct 2026

Crystallization Recall D-0876-2026; status Ongoing; distribution: U.S. Nationwide.

Official source: FDA enforcement report ↗

Brief written by VigiEye from the company's press release. Claims are the company's own. AI-assisted; check the source before acting.

More Quality & compliance All →